Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During Prehabilitation

NCT04041297

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: ADIR Association Bois-Guillaume, Normandy, France

View Trial Details

Completed

Effect of Two Different Preoperative Training Densities in Patients With Non-small-cell Lung Cancer Before Lung Resection Surgery

NCT03936764

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: ADIR Association Bois-Guillaume, Normandy, France

View Trial Details

Completed

Memory Preservation of Prophylactic Cranial Irradiation With Hippocampal Avoidance (PREMER-TRIAL)

NCT02397733

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations: Hospital Del Mar. Radiation Oncology Department Barcelona, Spain

View Trial Details

Completed

Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer

NCT02674568

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +12 more
Locations: Not specified

View Trial Details

Completed

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS

NCT03465241

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

NCT03098550

Conditions: Advanced Cancer, Breast Diseases, Breast Neoplasms, +19 more
Locations: Pacific Shores Medical Group Long Beach, California, United States

University Of Colorado Aurora, Colorado, United States

Moffitt Cancer Center Tampa, Florida, United States

University Of Michigan Ann Arbor, Michigan, United States

View all 20 locations

View Trial Details

Completed

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

NCT02410603

Conditions: Adenocarcinoma, Bronchial Neoplasms, Cancer of Lung, +21 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer

NCT01620190

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Anchorage Oncology Centre Anchorage, Alaska, United States

Katmai Oncology Group Anchorage, Alaska, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Bozeman Deaconess Hospital Bozeman, Montana, United States

View Trial Details

Completed

Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function

NCT03351140

Conditions: Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +37 more
Locations: GSK Investigational Site Mountlake Terrace, Washington, United States

View Trial Details

Completed

Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer

NCT02879994

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions